Cost Share Programme - Patient Privacy Statement
Roche would like you to know that we treat your personal information securely and in accordance with the Privacy Act, 2020 and Privacy Amendment Act 2025.
Roche, via the Blue Tree app and/or web portal, collects and stores your personal information (which may include but is not limited to name or initials, date of birth, gender, contact details such as address/email address, and health information). Programme administrator(s), in Roche New Zealand, will only have access to your initials and date of birth for the purposes of processing cost-share programme (“CSP”) activities.
Your health professional provides us with this personal information. You can choose not to consent to your health professional providing Roche with your personal information, but this may mean that we are unable to enrol you into a CSP or it may mean we are unable to communicate directly with you. If no email address is provided to Roche, emails will be sent to your health professional or treatment centre.
Personal information is collected, processed and stored on the Blue Tree app and/or web portal hosted by an authorised overseas entity. Roche uses technology and security precautions, rules and other procedures to protect your personal information from unauthorised access, improper use, disclosure, loss or destruction. To ensure the confidentiality of your personal information, Roche also uses industry standard firewalls and password protection.
Access to your personal information is limited only to Roche staff involved in CSP administration. Roche will keep your personal information, shared as part of the CSP, for 10 years, after which Roche will securely destroy it by erasing all digital information.
Personal information may be shared to Roche-authorised third parties, to fulfil CSP obligations or for legal, regulatory, pharmacovigilance or audit verification purposes. Any information received by Roche regarding any reportable safety information or side effect you experience on a Roche product (as part of a CSP) will be forwarded to Roche Patient Safety and shared to authorised overseas affiliates. Roche Patient Safety may contact your health professional for further information. Roche is required under the Medicines Act (1981) to request the collection of safety reportable information.
Roche takes reasonable steps to ensure that overseas entities will protect your personal information in a way that, overall, provides comparable safeguards to the Privacy Act, 2020. Examples of such reasonable steps include a written agreement between Roche and the overseas entity or making reasonable enquiries regarding the data protection standards of the country in which the recipient entity is located. Your participation in the CSP constitutes your consent for your personal information to be disclosed to overseas entities.
For more information about how Roche protects your privacy, view our Privacy Statement . You can contact Roche’s Privacy Officer at [email protected] to access or correct the information we hold about you.